{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:35:30Z","timestamp":1762522530860},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.21173","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T18:35:21Z","timestamp":1605724521000},"page":"e2021173","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents"],"prefix":"10.1001","volume":"3","author":[{"given":"Qiushi","family":"Chen","sequence":"first","affiliation":[{"name":"Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Harold and Inge Marcus Department of Industrial and Manufacturing Engineering, Pennsylvania State University, University Park"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgay","family":"Ayer","sequence":"additional","affiliation":[{"name":"H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline G.","family":"Adee","sequence":"additional","affiliation":[{"name":"Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[{"name":"H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas"},{"name":"Houston Veterans Affairs Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagpreet","family":"Chhatwal","sequence":"additional","affiliation":[{"name":"Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"1","key":"zoi200723r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016.","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"zoi200723r2","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/cncr.v122.9","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"zoi200723r3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma.","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"zoi200723r4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/cncr.v116:5","article-title":"Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.","volume":"116","author":"Artinyan","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"zoi200723r5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.7326\/M18-1397","article-title":"Overdose prevention through medical treatment of opioid use disorders.","volume":"169","author":"Volkow","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi200723r6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update.","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"zoi200723r7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.","volume":"56","author":"European Association For The Study Of The Liver","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"zoi200723r8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7326\/M14-0095","article-title":"The changing burden of hepatitis C virus infection in the United States: model-based predictions.","volume":"161","author":"Kabiri","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi200723r9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents.","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi200723r10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","article-title":"Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.","volume":"66","author":"Janjua","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"zoi200723r11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018.","volume":"69","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"zoi200723r13","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/hep.28571","article-title":"Hepatitis C disease burden in the United States in the era of oral direct-acting antivirals.","volume":"64","author":"Chhatwal","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"zoi200723r14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-154-2-201101180-00006","article-title":"Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.","volume":"154","author":"Davila","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi200723r15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/MCG.0000000000000708","article-title":"Hepatocellular carcinoma surveillance among patients with cirrhosis in a population-based integrated health care delivery system.","volume":"51","author":"Singal","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"zoi200723r16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/apt.15291","article-title":"The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.","volume":"50","author":"Chhatwal","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"zoi200723r17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, national health and nutrition examination survey 2003 to 2010.","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"issue":"24","key":"zoi200723r19","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"zoi200723r20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.v48:2","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"zoi200723r21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"zoi200723r22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis: a study of 200 patients.","volume":"40","author":"Planas","year":"2004","journal-title":"J Hepatol"},{"issue":"4, pt 2","key":"zoi200723r23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/ajt.2010.10.issue-4p2","article-title":"Trends in organ donation and transplantation in the United States, 1999-2008.","volume":"10","author":"Wolfe","year":"2010","journal-title":"Am J Transplant"},{"issue":"4, pt 2","key":"zoi200723r24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/ajt.2010.10.issue-4p2","article-title":"Liver transplantation in the United States, 1999-2008.","volume":"10","author":"Thuluvath","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"zoi200723r25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jval.2013.07.006","article-title":"Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.","volume":"16","author":"Chhatwal","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"zoi200723r26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2008.07.029","article-title":"The burden of illness associated with hepatocellular carcinoma in the United States.","volume":"50","author":"Lang","year":"2009","journal-title":"J Hepatol"},{"issue":"6","key":"zoi200723r28","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/hep.25556","article-title":"Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.","volume":"55","author":"Denniston","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"zoi200723r31","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.","volume":"52","author":"Cardoso","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"zoi200723r32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhep.2018.03.009","article-title":"Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.","volume":"69","author":"Romano","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"zoi200723r33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hep.24131","article-title":"Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.","volume":"53","author":"Stepanova","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"zoi200723r35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.v69.3","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"zoi200723r36","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13714","article-title":"Racial disparities in patient selection for liver transplantation: an ongoing challenge.","volume":"33","author":"Jesse","year":"2019","journal-title":"Clin Transplant"},{"key":"zoi200723r37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.04.022","article-title":"Liver-related mortality is similar among men and women with cirrhosis.","author":"Mazumder","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"zoi200723r39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jnci\/djy180","article-title":"Changing landscape of liver cancer in California: a glimpse into the future of liver cancer in the United States.","volume":"111","author":"Han","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"zoi200723r40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/jnci\/djy051","article-title":"Striking racial\/ethnic disparities in liver cancer incidence rates and temporal trends in California, 1988-2012.","volume":"110","author":"Pham","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi200723r41","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012.","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"zoi200723r42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/jnci\/djy184","article-title":"Hepatocellular carcinoma: a roadmap to reduce incidence and future burden.","volume":"111","author":"Singal","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi200723r43","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/hep.v57.6","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States.","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"zoi200723r44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"zoi200723r45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cgh.2014.07.056","article-title":"Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.","volume":"13","author":"McGowan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"zoi200723r46","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jhep.2016.06.009","article-title":"Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment.","volume":"65","author":"Kozbial","year":"2016","journal-title":"J Hepatol"},{"key":"zoi200723r47","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.","author":"Ioannou","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"zoi200723r48","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression.","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"zoi200723r49","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.cgh.2018.12.018","article-title":"Cost effectiveness of hepatocellular carcinoma surveillance after a sustained virologic response to therapy in patients with hepatitis C virus infection and advanced fibrosis.","volume":"17","author":"Farhang Zangneh","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"zoi200723r50","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.cgh.2019.02.020","article-title":"For whom is hepatocellular carcinoma surveillance after sustained virologic response cost-effective?","volume":"17","author":"Singal","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"zoi200723r51","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/hep.v69.5","article-title":"Early detection of hepatocellular carcinoma: expanding the utility of circulating tumor markers.","volume":"69","author":"Yang","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"zoi200723r52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"zoi200723r53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11901-017-0336-z","article-title":"Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?","volume":"16","author":"Goossens","year":"2017","journal-title":"Curr Hepatol Rep"},{"issue":"1","key":"zoi200723r54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction.","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"zoi200723r55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.v71.1","article-title":"Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents.","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"zoi200723r56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cgh.2019.07.042","article-title":"Provider attitudes and practice patterns for direct-acting antiviral therapy for patients with hepatocellular carcinoma.","volume":"18","author":"Rich","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"volume-title":"Medicaid Coverage and Care for the Homeless Population: Key Lessons to Consider for the 2014 Medicaid Expansion.","year":"2012","author":"Kates","key":"zoi200723r34"},{"key":"zoi200723r38","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006","edition":"1st ed"},{"key":"zoi200723r12","unstructured":"AASLD-IDSA. Monitoring patients who are starting HCV treatment, are on treatment, or have completed therapy: recommendations for testing, managing, and treating hepatitis C. Accessed January 1, 2019. https:\/\/www.hcvguidelines.org\/evaluate\/monitoring"},{"key":"zoi200723r18","unstructured":"Centers for Disease Control and Prevention. Surveillance for viral hepatitis \u2013 United States, 2011. Accessed November 20, 2013. https:\/\/www.cdc.gov\/HEPATITIS\/Statistics\/index.htm"},{"key":"zoi200723r27","unstructured":"US Preventive Services Task Force. Draft recommendation statement: hepatitis C virus infection in adolescents and adults: screening. Accessed September 30, 2019. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-recommendation-statement\/hepatitis-c-screening1"},{"key":"zoi200723r29","unstructured":"Hep C State Policy Simulator. Accessed July 30, 2020. https:\/\/www.hepcsimulator.org\/"},{"key":"zoi200723r30","unstructured":"HepCorrections. Estimates of treatment uptake among incacerated population. Accessed October 30, 2019. http:\/\/www.hepcorrections.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2773070\/chen_2020_oi_200723_1605044903.02771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T16:30:26Z","timestamp":1723912226000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2773070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.21173","relation":{},"ISSN":["2574-3805"],"issn-type":[{"type":"electronic","value":"2574-3805"}],"subject":[],"published":{"date-parts":[[2020,11,18]]}}}